Back to results
US 2021/0171637 A1Published application
Anti-b7-h3 antibodies and antibody drug conjugates
AssigneeAbbVie Inc.
InventorsLorenzo Benatuil, Debra Chao, Kamel Izeradjene, Andrew S. Judd, Andrew C. Phillips, Andrew J. Souers, Archana Thakur, Milan Bruncko
Life of this patent
Estimating the term…
Abstract
The invention relates to B7 homology 3 protein (B7-H3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Claims16
An isolated anti-hB7H3 antibody, wherein the antibody comprises
- a heavy chain variable region comprising
- a CDR3 having an amino acid sequence selected from the group consisting of SEQ ID NO:
- 12, SEQ ID NO:
- 35, and SEQ ID NO:
- 27.
- and a light chain variable region comprising
- a CDR3 having an amino acid sequence selected from the group consisting of of SEQ ID NO:
- 15, SEQ ID NO:
- 39, and SEQ ID NO:
- 31;
- a CDR2 having an amino acid sequence selected from the group consisting of SEQ ID NO:
- 7, SEQ ID NO:
- 38, and SEQ ID NO:
- 30;
- and
- a CDR1 having an amino acid sequence selected from the group consisting of SEQ ID NO:
- 136, SEQ ID NO:
- 138, SEQ ID NO:
- 37, SEQ ID NO:
- 14, and SEQ ID NO:
- 29.
18 more elements
2-12. (canceled)
14-22. (canceled)
24-31. (canceled)
(canceled)
(canceled)
37-129. (canceled)
133-137. (canceled)
Dependencies are inferred from the claim text.